Impacts of Time-Restricted Eating on Weight, Cardiometabolic and Cardiovascular Health in Patients With Acute Coronary Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- Change in weight
研究概览
简要总结
The goal of this clinical trial is to learn about the effects of time-restricted eating in patients with history of acute coronary syndrome. The main questions it aims to answer are: 1) Is 10-hr TRE safe and feasible for patients with ACS; 2)What are the impacts of 10-hr TRE on anthropometric measurements, cardiometabolic health and cardiovascular health compared to ad libitum eating in patients with ACS?. Participants will be asked to limit eating duration to 10 hours daily.
详细描述
Justification: The effects of TRE on humans varies results, with some showing improvements in weight loss, insulin sensitivity, and cardiovascular markers, while others exhibiting no significant changes. TRE studies on metabolically altered individuals especially patients with heart diseases are limited.
Written approval of the study has been obtained from the Universiti Teknologi MARA Ethics Committee before commencement of this study.
The TRES study utilizes an investigator-led, pragmatic, parallel, randomized, single-blinded clinical trial design to evaluate the safety, feasibility, and effectiveness of a 10-hour time-restricted eating (TRE) intervention compared to unrestricted eating in patients diagnosed with acute coronary syndrome. The study aims to assess the impact of TRE on anthropometric measurements, as well as cardiometabolic and cardiovascular health outcomes. The duration of the randomized controlled trial (RCT) spans a period of five weeks. The trial consisted of a baseline period of one week, which was then followed by a four-week intervention phase. The participants will be assigned randomly to either the TRE (Time-Restricted Eating) group or the control group, which involves ad libitum eating. They will be instructed to adhere to their allotted eating duration during the four-week intervention period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult, 18- 65 years old.
- •Had history of acute coronary syndrome (ACS)
- •Clinically stable
- •Self-reported eating window of at least 12 h per day.
排除标准
- •Severe obesity (body mass index ≥40 kg m-2).
- •Unstable weight in the past three months (gain or lose more than 4 kg of weight).
- •Unstable cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that may compromise study validity.
- •Any medications or supplements known to change sleep, circadian rhythms, or metabolism.
- •Pregnant or lactating women.
- •Perform overnight shift work more than one day/week on average.
- •Regularly fasted for more than 15 hours/day or having completed twelve 24-hr fasts within the past three months).
- •Active use of tobacco or illicit drug or history of treatment for alcohol abuse.
- •Type I diabetes or diabetic, treated with insulin.
- •Use of anti-obesity drugs or other drugs affecting body weight.
- •Currently enrolled in weight loss or management programme, including surgical intervention.
- •Severe kidney failure (glomerular filtration rate (GFR) <30 mL/min).
- •Eating disorder or current diagnosis of uncontrolled psychiatric illness, which may impair study involvement.
- •Malignancy undergoing active treatment.
- •Had gastrointestinal surgery or impaired nutrient absorption.
- •Travelled more than two time zones away two months prior to enrolling in the trial or will travel more than two time zones away during the study period.
- •Concurrent participation in other interventional studies
结局指标
主要结局
Change in weight
时间窗: 4 weeks (pre- & post intervention)
unit: kg
次要结局
- Change in lean body mass(4 weeks (pre- & post intervention))
- Adverse event monitoring(4 weeks)
- Change in perceived appetite(4 weeks (pre- & post intervention))
- Change in Hemoglobin level(4 weeks)
- Change in high-density lipoprotein concentration(4 weeks (pre- & post intervention))
- Change in C-reactive protein concentration(4 weeks (pre- & post intervention))
- Change in Malondialdehyde (MDA) level(4 weeks (pre- & post intervention))
- Change in fasting glucose concentration(4 weeks (pre- & post intervention))
- Change in total cholesterol concentration(4 weeks (pre- & post intervention))
- Change in low-density lipoprotein concentration(4 weeks (pre- & post intervention))
- Change in flow-mediated dilatation,(4 weeks (pre- & post intervention))
- Change in Brachial-ankle pulse wave velocity(4 weeks (pre- & post intervention))
- Change in fasting insulin concentration(4 weeks (pre- & post intervention))
- Change in triglycerides concentration(4 weeks (pre- & post intervention))
- Change in fat mass(4 weeks (pre- & post intervention))
- Change in physical activity(4 weeks (pre- & post intervention))
- Change in sleep quality(4 weeks (pre- & post intervention))
研究者
MAZUIN KAMARUL ZAMAN
Principal Investigator
Universiti Teknologi Mara